“…The CHA use in mental disorders is closely related to the characteristics of the disease, side effects or addictive potential of medications, fear of stigma, socio‐demographic characteristics of the patients (age, sex, education, economic status, social support network), belief system, cultural or ethnic origin, lack of a standard control mechanism and therefore ease of access to products 7,10,12,13 . In literature, it is reported that the prevalence of CHA in patients with mental disorders varies between 3.6% and 89%, and patients use CHA with or without medical treatment 7,13–18 …”